Latest biopharmaceutical Stories
DALLAS and NEW YORK, Dec. 18, 2014 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
-- ContraVir to develop CMX157 for multiple antiviral indications -- DURHAM, N.C. and EDISON, N.J., Dec. 18, 2014 /PRNewswire/ -- Chimerix, Inc.
Experimental monoclonal antibody to be used in clinical trials with patients in West Africa infected with the Ebola virus.
The company leverages its keen understanding of protein purification to achieve the highest purification standards and product quality LONDON, Dec.
NEW YORK, Dec.
BIRMINGHAM, Ala. and BATON ROUGE, La. and RALEIGH, N.C. and RESEARCH TRIANGLE PARK, N.C., Dec.
HERZLIYA, Israel, Dec.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had
Led by CSL Behring performance, the company focuses on sustainable business practices, strong results to provide patients with lifesaving, life-enhancing therapies around the world. KING OF
- A transitional zone between two communities containing the characteristic species of each.